Sept 23 (Reuters) - Ainos Inc :
* AINOS INC: PLAN TO INITIATE TAIWAN CLINICAL STUDY OF VELDONA FOR TREATING SJÖGREN'S SYNDROME, A RARE DISEASE WITH LIMITED TREATMENT OPTIONS
* AINOS INC: AIMS TO COMPLETE ALL REGULATORY APPROVALS FOR STUDY IN Q4 2024
Further company coverage:
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.